Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 10 studies | 35% ± 13% | |
macrophage | 9 studies | 33% ± 17% | |
myeloid cell | 7 studies | 21% ± 7% | |
glutamatergic neuron | 6 studies | 43% ± 25% | |
GABAergic neuron | 4 studies | 46% ± 17% | |
interneuron | 3 studies | 33% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 2633.65 | 2600 / 2642 | 96% | 10.27 | 680 / 705 |
lung | 85% | 753.14 | 489 / 578 | 93% | 8.07 | 1070 / 1155 |
breast | 69% | 320.91 | 318 / 459 | 94% | 9.85 | 1056 / 1118 |
intestine | 69% | 480.26 | 664 / 966 | 89% | 12.10 | 469 / 527 |
bladder | 52% | 259.86 | 11 / 21 | 87% | 10.88 | 439 / 504 |
prostate | 64% | 300.08 | 157 / 245 | 70% | 5.88 | 350 / 502 |
stomach | 40% | 158.03 | 143 / 359 | 91% | 9.75 | 259 / 286 |
adrenal gland | 91% | 553.53 | 235 / 258 | 37% | 1.79 | 84 / 230 |
kidney | 39% | 197.35 | 35 / 89 | 82% | 6.17 | 740 / 901 |
skin | 34% | 173.38 | 624 / 1809 | 83% | 9.56 | 394 / 472 |
uterus | 35% | 127.02 | 59 / 170 | 80% | 6.29 | 365 / 459 |
esophagus | 27% | 104.57 | 385 / 1445 | 87% | 5.37 | 160 / 183 |
ovary | 14% | 54.77 | 26 / 180 | 93% | 7.61 | 398 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.15 | 29 / 29 |
spleen | 100% | 2409.74 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.43 | 1 / 1 |
pancreas | 12% | 56.41 | 40 / 328 | 87% | 5.80 | 155 / 178 |
peripheral blood | 98% | 2674.65 | 913 / 929 | 0% | 0 | 0 / 0 |
thymus | 36% | 152.31 | 234 / 653 | 53% | 3.07 | 323 / 605 |
tonsil | 0% | 0 | 0 / 0 | 87% | 6.51 | 39 / 45 |
adipose | 81% | 489.65 | 974 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 6.09 | 55 / 80 |
liver | 15% | 64.23 | 35 / 226 | 31% | 1.44 | 125 / 406 |
blood vessel | 45% | 290.53 | 602 / 1335 | 0% | 0 | 0 / 0 |
heart | 7% | 27.07 | 62 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 3.19 | 7 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002407 | Biological process | dendritic cell chemotaxis |
GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
GO_0051489 | Biological process | regulation of filopodium assembly |
GO_0009408 | Biological process | response to heat |
GO_0071502 | Biological process | cellular response to temperature stimulus |
GO_0071577 | Biological process | zinc ion transmembrane transport |
GO_0097553 | Biological process | calcium ion transmembrane import into cytosol |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0098703 | Biological process | calcium ion import across plasma membrane |
GO_0014074 | Biological process | response to purine-containing compound |
GO_0033194 | Biological process | response to hydroperoxide |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0097028 | Biological process | dendritic cell differentiation |
GO_0071421 | Biological process | manganese ion transmembrane transport |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0071415 | Biological process | cellular response to purine-containing compound |
GO_0001659 | Biological process | temperature homeostasis |
GO_0006816 | Biological process | calcium ion transport |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0051289 | Biological process | protein homotetramerization |
GO_0035579 | Cellular component | specific granule membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0043204 | Cellular component | perikaryon |
GO_0005764 | Cellular component | lysosome |
GO_0070821 | Cellular component | tertiary granule membrane |
GO_0101003 | Cellular component | ficolin-1-rich granule membrane |
GO_0042995 | Cellular component | cell projection |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0005272 | Molecular function | sodium channel activity |
GO_0016787 | Molecular function | hydrolase activity |
GO_0005261 | Molecular function | monoatomic cation channel activity |
GO_0099604 | Molecular function | ligand-gated calcium channel activity |
GO_0005384 | Molecular function | manganese ion transmembrane transporter activity |
GO_0072571 | Molecular function | mono-ADP-D-ribose binding |
GO_0047631 | Molecular function | ADP-ribose diphosphatase activity |
GO_0015278 | Molecular function | intracellularly gated calcium channel activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | TRPM2 |
Protein name | TRPM2 protein Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2) (LTrpC-2) (LTrpC2) (Transient receptor potential channel 7) (TrpC7) (Transient receptor potential melastatin 2) Truncated tumor-enriched TRPM2 (cDNA FLJ50244, highly similar to Transient receptor potential cation channel subfamily M member 2) Transient receptor potential cation channel, subfamily M, member 2, striatum short form (SSF-TRPM2) Transient receptor potential cation channel subfamily M member 2 |
Synonyms | LTRPC2 EREG1 KNP3 TRPC7 |
Description | FUNCTION: [Isoform 1]: Nonselective, voltage-independent cation channel that mediates Na(+) and Ca(2+) influx, leading to increased cytoplasmic Ca(2+) levels . Functions as a ligand-gated ion channel . Binding of ADP-ribose to the cytoplasmic Nudix domain causes a conformation change; the channel is primed but still requires Ca(2+) binding to trigger channel opening . Extracellular calcium passes through the channel and increases channel activity . Contributes to Ca(2+) release from intracellular stores in response to ADP-ribose . Plays a role in numerous processes that involve signaling via intracellular Ca(2+) levels (Probable). Besides, mediates the release of lysosomal Zn(2+) stores in response to reactive oxygen species, leading to increased cytosolic Zn(2+) levels . Activated by moderate heat (35 to 40 degrees Celsius) . Activated by intracellular ADP-ribose, beta-NAD (NAD(+)) and similar compounds, and by oxidative stress caused by reactive oxygen or nitrogen species . The precise physiological activators are under debate; the true, physiological activators may be ADP-ribose and ADP-ribose-2'-phosphate . Activation by ADP-ribose and beta-NAD is strongly increased by moderate heat (35 to 40 degrees Celsius) . Likewise, reactive oxygen species lower the threshold for activation by moderate heat (37 degrees Celsius) . Plays a role in mediating behavorial and physiological responses to moderate heat and thereby contributes to body temperature homeostasis. Plays a role in insulin secretion, a process that requires increased cytoplasmic Ca(2+) levels (By similarity). Required for normal IFNG and cytokine secretion and normal innate immune immunity in response to bacterial infection. Required for normal phagocytosis and cytokine release by macrophages exposed to zymosan (in vitro). Plays a role in dendritic cell differentiation and maturation, and in dendritic cell chemotaxis via its role in regulating cytoplasmic Ca(2+) levels (By similarity). Plays a role in the regulation of the reorganization of the actin cytoskeleton and filopodia formation in response to reactive oxygen species via its role in increasing cytoplasmic Ca(2+) and Zn(2+) levels . Confers susceptibility to cell death following oxidative stress . .; FUNCTION: [Isoform 2]: Lacks cation channel activity. Does not mediate cation transport in response to oxidative stress or ADP-ribose. .; FUNCTION: [Isoform 3]: Lacks cation channel activity and negatively regulates the channel activity of isoform 1. Negatively regulates susceptibility to cell death in reposponse to oxidative stress. . |
Accessions | ENST00000300482.9 [O94759-1] Q14DR2 O94759 ENST00000397932.6 E9PGK7 ENST00000431901.5 ENST00000397928.6 [O94759-1] B4DVI8 C9JZQ8 Q5KTC1 ENST00000300481.13 [O94759-2] |